Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial

PURPOSE: Previous studies have suggested an association between metformin use and improved outcome in patients with diabetes and breast cancer. In the current study, we aimed to explore this association in human epidermal growth factor receptor 2 (HER2 ) –positive primary breast cancer in the contex...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Oncol
Auteurs principaux: Sonnenblick, Amir, Agbor-Tarh, Dominique, Bradbury, Ian, Di Cosimo, Serena, Azim, Hatem A., Fumagalli, Debora, Sarp, Severine, Wolff, Antonio C., Andersson, Michael, Kroep, Judith, Cufer, Tanja, Simon, Sergio D., Salman, Pamela, Toi, Masakazu, Harris, Lyndsay, Gralow, Julie, Keane, Maccon, Moreno-Aspitia, Alvaro, Piccart-Gebhart, Martine, de Azambuja, Evandro
Format: Artigo
Langue:Inglês
Publié: American Society of Clinical Oncology 2017
Sujets:
ORIGINAL REPORTS
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5455460/
https://ncbi.nlm.nih.gov/pubmed/28375706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.69.7722
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires